Logo

Concord Biotech Ltd. Share Price

Pharmaceuticals & Drugs

Concord Biotech Ltd. (INR)1518.6-39.2   (-2.5%)

Exchange ScripsBSE543960NSECONCORDBIOISININE338H01029

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Concord Biotech Ltd. Performance

Market performance

Open price1583
High1583
Volumes100275
Prev Close1518.6
Low1510.1
Closing date2025-04-30

Historical performance

1 Year High2664.00
3 Year High2664.00
5 Year High2664.00
1 Year Low1327.05
3 Year Low900.05
5 Year Low900.05

Concord Biotech Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
16174
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
51.56
Dividend Yield
Dividend Yield
0.58 %

Concord Biotech Ltd. Investment Returns

1 Year
-8.9%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Concord Biotech Ltd. Technicals

IndicatorsValueSignal
5-DMA1573.68Bearish
10-DMA1637.1Bearish
20-DMA1647.98Bearish
50-DMA1675.15Bearish
100-DMA1921.47Bearish
200-DMA1884.38Bearish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters66666
Foreign Investors---------------
Domestic Investors66666
Public Investors8121381998842928073183290
Government---------------

Concord Biotech Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income338353234138
Operating Profit4660383929733417
Interest32986110
Depreciation536540500275
Profit Before Tax4126322023753127
Consolidated Net Profit3081240117492348
Adjusted EPS29231722

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1051059595
Total Reserves1516212795109379899
Minority Interest------------
Total Non-Current Liabilities319321544774
Total Liabilities17007151401501913127
Capital Work in Progress21151727742179
Total Assets17007151401501913127

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities2655246020751668
Cash Flow from Investing Activities-1546-1580-1118-1952
Cash Flow from Financing Activitie-992-852-1002311
Net Cash Inflow / Outflow11628-4527
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 51.56.
  • 3Y Stock Price CAGR of the stock is 61.1.
  • The stock has a beta of 0.9.
  • In the last financial year, the company had an EBITDA of ₹4660 Million.
  • The company generated revenue of ₹10169 Million in the previous financial year.

Concord Biotech Ltd.

1518.6-39.2   (-2.5%)

Investment Amount: ₹ 1000000
Current Value: ₹ 915425.9
No. of Shares: 602.8
Performance:-8.5%
P/L: ₹-84574.1

Top Gainers

SymbolChange%
SONATSOFTW421.55(12%)
ABINFRA88.96(11%)
VMM118.48(10%)
JETFREIGHT14.77(10%)
GLOBALVECT220.9(10%)

Top Losers

SymbolChange%
PREMEXPLN416.2(-11%)
PRAJIND461.3(-9%)
GTECJAINX25.6(-9%)
MADHUCON6.85(-8%)
AMBICAAGAR26.8(-8%)
GSS37.6(-8%)
OSWALAGRO78.03(-8%)
WALCHANNAG180.82(-8%)

Similar stocks

Aarey Drugs & Pharmaceuticals Ltd.

60.1

53.65

March 30 - April 30

Hester Biosciences Ltd.

42.1

1782.9

March 30 - April 30

Sakar Healthcare Ltd.

28.3

271.56

March 30 - April 30

Valiant Laboratories Ltd.

25.9

96.4

March 30 - April 30

Morepen Laboratories Ltd.

25.8

60.17

March 30 - April 30

Panacea Biotec Ltd.

25.1

552.15

March 30 - April 30

Brooks Laboratories Ltd.

24.2

132.1

March 30 - April 30

Bal Pharma Ltd.

21.8

102.15

March 30 - April 30

Announcing Stock of the Month!

Stock of the Month
Stock of the Month